Deep Blue Medical Advances Closes Successful Series A1 Funding Round
PRIVATEJun 28, 2022
Round Type
Series A
DurhamBiotechnologyConsumer Goodsmedical devices
Description
Deep Blue Medical Advances, developer of the T-Line® Hernia Mesh, today announced the close of its Series A1 funding round. This capital will enable Deep Blue Medical to scale up its commercialization and product development efforts to meet rapidly increasing market demand for its T-Line Hernia Mesh.
Who to call at Deep Blue Medical Advances, and when
A new round usually means Deep Blue Medical Advances is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Deep Blue Medical Advances raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Deep Blue Medical Advances, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Deep Blue Medical Advances
Location
701 W. Main St
Durham, North Carolina, United States
About
Deep Blue Medical Advances, a Duke University spin-out, is transforming hernia repair with its surgeon-invented T-Line® Hernia Mesh, designed to address the high global rates of hernia occurrence and recurrence. Featuring integral suture-like extensions, the mesh eliminates a key failure point in conventional fixation—the mesh-suture-tissue interface—while providing superior anchor strength. With additional products in development, including an anchor clip, a biosynthetic mesh, and a coated composite version, Deep Blue is poised to make a significant impact on the $1.1B global hernia device market by reducing fixation failure and improving surgical outcomes.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Deep Blue Medical Advances raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DurhamBiotechnologyConsumer Goodsmedical devices